Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The increase in risk was small approximately three to four additional cases per 10,000 patients treated with GLP-1s over 18 months, but clinicians and patients should be aware of this potential association. Researchers said while the risk is low, the rising use of GLP-1s in patients with and without Type 2 diabetes warrants special attention to medication safety
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, et al
This is a real risk
A large multicenter database study confirmed this association
US$ 25.19
US$ 28.11
US$ 26.89
